Working Paper Brief Report Version 2 This version is not peer-reviewed

Are we on the Right Way after 200 Days of COVID-19 in Morocco?

Version 1 : Received: 23 September 2020 / Approved: 24 September 2020 / Online: 24 September 2020 (10:45:21 CEST)
Version 2 : Received: 5 November 2020 / Approved: 5 November 2020 / Online: 5 November 2020 (10:40:41 CET)

How to cite: Bennis, I.; Nasri Sahraoui, A.; Alaoui, M.M. Are we on the Right Way after 200 Days of COVID-19 in Morocco?. Preprints 2020, 2020090576 Bennis, I.; Nasri Sahraoui, A.; Alaoui, M.M. Are we on the Right Way after 200 Days of COVID-19 in Morocco?. Preprints 2020, 2020090576

Abstract

Historically, 2020 will be remembered as the year of COVID-19 pandemic, that limited people move and their social habits. This virus, becomes the first daily tracked public health burden that leads to more than 1,2 million deaths in the World by the end of October 2020, and until now no countries' best control strategies are cited as the example of long term success.Since March 2nd, 2020, date of the first SARS-COV-2 detected case in Morocco; many decisions were adopted as COVID-19 control strategies. If the first period of COVID-19 noticed a few numbers of cases and deaths, the second half from July is marked with an exponential increase of the number of cases and a spread in almost all provinces with more intensive care needs and more deaths. The policy analysis approach was followed as a method to define the pitfalls themes and to compare with the updated available international information any significant similarities or divergences. Thus, this report has the aim to present an overview of how the COVID-19 pandemic was dealt in Morocco during these 200 days, by highlighting some discrepancies with corrective advice provided in the first version of the manuscript to be confronted by a Moroccan health policymaker’s community, then to notice the decisions adopted during another one month by the MoH to get better future control results against COVID-19.Unfortunately, despite the MoH decision to increase the diagnostic facilities for molecular tests, the overall number of laboratory tests do not go further than 21000 tests per day. The actual insidious transmission is a dangerous blind threat that dissipates the collaborating efforts, due to this limited number of confirmation and follows up tests.Accurate, standardised and up to ten times per day tests of molecular biology represented by RT-qPCR, to interpret results following the time progress of cycle quantification values is the primary action to be done to enhance the overall control strategy.

Keywords

COVID-19; SARS-CoV-2; RT-PCR; control strategy; Morocco

Subject

Biology and Life Sciences, Biochemistry and Molecular Biology

Comments (1)

Comment 1
Received: 5 November 2020
Commenter: Issam Bennis
Commenter's Conflict of Interests: Author
Comment: Two other co authors joigned the board. 
Total enhancement of the text writing is performed in this second version, that become more concise with a reduction of total count of the words, without change on the general structure or on the study question. with update of the information and references as scheduled previousely in the method section. We added a small introductif paragraph in the abstract section and we added at the end of the discussion a paragraph about the limits of the study and we added an extra section about acknowledgements. However, we discarded one table not really informatif. 
The track change comparison between the both versions will show exactely all modifications. 
+ Respond to this comment

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 1
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.